Advertisement
Original Article| Volume 90, ISSUE 1, P87-91, May 2000

Malignant germ cell tumors of the ovary

Pregnancy considerations

      Abstract

      Objective: To study the pregnancy association and malignant germ cell tumors of the ovary with regard to its effects on tumor prognosis. Study Design:: Seventy-five patients with malignant germ cell tumors of the ovary treated at the King Faisal Specialist Hospital-Research Center (KFSH–RC) Riyadh, Kingdom of Saudi Arabia between January 1976 and December 1992, were reviewed. Data was retrieved from the medical records and the database of ovarian tumor pathology. Patients with tumor/pregnancy association were identified and correlation with obstetrical outcome and tumor prognosis analyzed. Patients who conceived after treatment were identified and their reproductive outcome described. Results: Malignant germ cell tumor was associated with pregnancy in a group of ten patients. Possible tumor effects upon pregnancy in this group included operative delivery by caesarean section (n=3), mid-trimester termination (n=2), spontaneous abortion (n=1). Four patients had normal vaginal birth with no apparent tumor effects upon pregnancy. Pregnancy did not seem to influence the tumor prognosis of pure dysgerminoma (n=6), however, two patients with non-dysgerminomatous germ cell tumor (one endodermal sinus tumor and one immature teratoma) died of rapidly progressive disease during the second trimester. Two patients with advanced (stage IIIC) disease concurrent with pregnancy (one pure dysgerminoma and one mixed germ cell tumor), had normal fetal outcomes and achieved long-term survival. Amongst the 22 patients who planned to conceive after conservative surgery, with or without post-operative adjuvant chemotherapy, 12 conceived (12/22) and achieved a total of 20 pregnancies. Their outcomes included normal births (n=18) including one set of twins and hydatidiform moles (n=2). Conclusions: Our findings suggest that, (1) The association of pure dysgerminoma and pregnancy did not adversely affect the tumor prognosis or fetal outcome. However, the question remains as to whether pregnancy worsened the prognosis of non-dysgerminomatous germ cell tumors. (2) Recent platinum-based regimens of multiagent chemotherapy for germ cell tumors did not seem to affect fertility potential.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Malone J.M.
        • Gershenson D.M.
        • Creasy R.K.
        • Kavanagh J.J.
        • Silva E.G.
        • Stringer C.A.
        Endodermal sinus tumor of the ovary associated with pregnancy.
        Obstet Gynecol. 1986; 68: 86S-89S
        • Thomas G.M.
        • Dembo A.J.
        • Hacker N.F.
        • DePetrillo A.D.
        Current therapy for dysgerminoma of the ovary.
        Obstet Gynecol. 1987; 70: 268-275
        • Creasman W.T.
        • Soper J.T.
        Assessment of the contemporary management of germ cell malignancies of the ovary.
        Am J Obstet Gynecol. 1985; 53: 828-834
        • Vergote I.B.
        • Abeler V.M.
        • Kjorstad K.E.
        • Trope C.
        Management of malignant ovarian immature teratoma-role of Adriamycin.
        Cancer. 1990; 66: 882-886
        • Rustin G.J.S.
        Managing malignant ovarian germ cell tumors.
        Br Med J. 1987; 295: 869-870
        • Thurlbeck W.M.
        • Scully R.E.
        Solid teratoma of the ovary: A clinical-pathologic analysis of 9 cases.
        Cancer. 1960; 13: 804-811
        • Creasman W.T.
        New gynecologic cancer staging.
        Obstet Gynecol. 1990; 75: 287-288
        • Karlen J.R.
        • Akbari A.
        • Cook W.A.
        Dysgerminoma associated with pregnancy.
        Obstet Gynecol. 1979; 53: 331-334
        • Creasman W.T.
        • Rutledge F.
        • Smith J.P.
        Carcinoma of the ovary associated with pregnancy.
        Obstet Gynecol. 1971; 38: 111-116
        • Novak E.R.
        • Lambrou C.D.
        • Woodruff J.D.
        Ovarian tumors in pregnancy.
        Obstet Gynecol. 1975; 46: 401-406
        • Krepart G.
        • Smith J.P.
        • Rutledge F.
        • et al.
        The treatment of dysgerminoma of the ovary.
        Cancer. 1978; 41: 986-990
        • Farahmand S.M.
        • Marchetti D.L.
        • Asirwatham J.E.
        • Dewey M.R.
        Ovarian endodermal sinus tumor associated with pregnancy: Review of the literature.
        Gynecol Oncol. 1991; 41: 156-160
        • Schwartz R.P.
        • Chatwani A.J.
        • Putong P.B.
        Endodermal sinus tumor in pregnancy: Report of a case and review of literature.
        Gynecol Oncol. 1983; 15: 434-439
        • Petrucha R.A.
        • Ruffolo E.
        • Prophat H.
        Endodermal sinus tumor: Report of a case associated with pregnancy.
        Obstet Gynecol. 1980; 55: 90S-93S
        • Azoury R.S.
        • Nasr M.F.
        • Muawwad R.F.
        The endodermal sinus tumor: Special features.
        Int J Gynecol Obstet. 1979; 17: 164-171
        • Kurman R.J.
        • Norris H.J.
        Endodermal sinus tumor of the ovary: A clinico-pathologic analysis of 71 cases.
        Cancer. 1976; 38: 2404-2419
        • Weed J.C.
        • Roh R.A.
        • Mendenhall H.W.
        Recurrent endodermal sinus tumor during pregnancy.
        Obstet Gynecol. 1979; 54: 653-656
        • Van der Zee A.G.J.
        • Bruijin H.W.A.
        • Bouma J.
        • Vries E.G.E.
        Endodermal sinus tumor of the ovary during pregnancy: A case report.
        Am J Obstet Gynecol. 1991; 164: 504-507
        • Serov S.F.
        • Scully R.E.
        • Sobin L.H.
        Histological typing of ovarian tumors. International histological classification of tumors. No. 9. World Health Organization, Geneva1973
        • Gershenson D.M.
        • Del Junco G.
        • Copeland L.J.
        • Rutledge F.N.
        Mixed germ cell tumors of the ovary.
        Obstet Gynecol. 1984; 64: 200-206
        • Gershenshon D.M.
        • Morris M.
        • Cangir A.
        • Kavanagh J.J.
        • Stringer C.A.
        • Edwards C.L.
        • Silva E.G.
        • Wharton J.T.
        Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin.
        J Clin Oncol. 1990; 18: 715-720
        • Jimerson G.K.
        • Woodruff J.D.
        Ovarian extraembryonal teratoma: II Endodermal sinus tumor mixed with other germ cell tumors.
        Am J Obstet Gynecol. 1977; 127: 302-304
        • Forney J.P.
        • DiSaia P.J.
        • Morrow P.C.
        Endodermal sinus: A report of two sustained remissions treated postoperatively with a combination of actinomycin-D, 5-fluorouracil and cyclosphosphamide.
        Obstet Gynecol. 1975; 45: 186-189
        • Creasman W.T.
        • Fetter B.F.
        • Hammond C.B.
        • et al.
        Germ cell malignancies of the ovary.
        Obstet Gynecol. 1979; 53: 226-230
        • Malkasian G.D.
        • Webb M.J.
        • Jorgensen E.O.
        Observations on chemotherapy of granulosa cell carcinoma and malignant ovarian teratomas.
        Obstet Gynecol. 1974; 44: 885-888
        • Slayton R.E.
        • Hreshchyshyn M.M.
        • Silverberg S.G.
        • et al.
        Treatment of malignant ovarian germ cell tumor.
        Cancer. 1978; 42: 390-398
        • Gershenson D.M.
        Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors.
        J Clin Oncol. 1988; 6: 270-275
        • Schilsky R.L.
        • Lewis B.J.
        • Sherins R.J.
        • et al.
        Gonadal dysfunction in patients receiving chemotherapy for cancer.
        Ann Intern Med. 1980; 93: 109-114
        • Nicosia S.V.
        • Matus-Ridley M.
        • Meadows A.T.
        Gonadal effects of cancer therapy in girls.
        Cancer. 1985; 55: 2364-2372
        • Sobrinho L.G.
        • Levine R.A.
        • DeConti R.C.
        Amenorrhea in patients with Hodgkin’s disease treated with antineoplastic drugs.
        Am J Obstet Gynecol. 1971; 109: 135-139
        • Horning S.J.
        • Hoppe R.T.
        • Kaplan H.S.
        • et al.
        Female reproductive potential after treatment for Hodgkin’s disease.
        N Engl J Med. 1981; 304: 1377-1382
        • Siris E.S.
        • Leventhal B.G.
        • Vaitukaitis J.L.
        Effects of childhood leukemia and chemotherapy on puberty and reproductive function in girls.
        N Engl J Med. 1976; 294: 1143-1146
        • Schwartz P.E.
        • Chambers S.K.
        • Chambers J.T.
        • Kohorn E.
        • McIntosh S.
        Ovarian germ cell malignancies: The Yale University experience.
        Gynecol Oncol. 1992; 45: 26-31